ProBioGen and Marea Therapeutics Inc. have successfully completed a sprint project to deliver clinical material for MAR002.

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

EVast Bio, a U.S.-based clinical-stage biotech company, has achieved an important milestone by conducting the world’s first ...

Over $100 Million Invested in the U.S. FREMONT, CA - March 5, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ...

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on inflammation and immunology biological products and contract develo ...

Acadia Pharmaceuticals Inc. today announced that the journal Med published results from the open-label study, DAFFODILtm, evaluating the safety, tolerability and exploratory efficacy of DAYBUE® ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Argent BioPharma (ASX: RGT) has announced a strategic manufacturing partnership with ECCPharm Limited, a leading ...

Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.

Enzene’s two facilities in Pune, India have received European Union (EU) GMP certification to provide commercial-scale ...